Gregory Cooper, MD
- Co-Program Leader for Cancer Prevention and Control, UH Seidman Cancer Center
- Program Director, Gastroenterology, UH Cleveland Medical Center
- Co-Program Leader for Cancer Prevention and Control, UH Cleveland Medical Center
- Professor, CWRU School of Medicine
- Gastrointestional Cancer
Patient Satisfaction Reviews
4.9 out of 5
Patient Comments (8)
Reviewed On 10/1/2020
Friendly and very knowledgeable
Reviewed On 9/1/2020
The provider and his office have been excellent so far. ***
Reviewed On 8/4/2020
Doctor Cooper is a good doctor and very kind and compassionate... I have been with him over ten years...
Reviewed On 5/1/2020
My most recent visit was a tele health appointment. Dr. Cooper and all the staff that I interacted with via phone were courteous and very helpful.
Reviewed On 3/30/2020
I have always felt confident with Dr. Cooper's care and trust him with the treatment of my condition.
Reviewed On 2/7/2020
Dr. Cooper is amazing. I've recommended him to my parents and three of my friends. They are all now his patients. He cannot ever retire!
Reviewed On 12/26/2019
Dr. Cooper is the absolute best provider; University Hospitals is luck to have him.
Reviewed On 12/10/2019
he is a really nice doctor
- Gastroenterology - American Board of Internal Medicine
- Internal Medicine - American Board of Internal Medicine
Research Fellowship | Gastroenterology
Gastroenterology - University Hospitals Of Cleveland (1992 - 1993)
Residency | Internal Medicine/Chief Resident
Internal Medicine/Chief Resident - University Hospitals Of Cleveland (1991 - 1992)
Fellowship | Gastroenterology
Gastroenterology - University Hospitals Of Cleveland (1989 - 1991)
Residency | Internal Medicine
Internal Medicine - University Hospitals Of Cleveland (1987 - 1989)
Internship | Internal Medicine
Internal Medicine - University Hospitals Of Cleveland (1986 - 1987)
University Of Pennsylvania School Of Medicine (1986)
University Of Pennsylvania (1982)
University Of Pennsylvania (1982)
University Hospitals is committed to transparency in our interactions with industry partners, such as pharmaceutical, biotech, or medical device companies. At UH, we disclose practitioner and their family members’ ownership and intellectual property rights that are or in the process of being commercialized. In addition, we disclose payments to employed practitioners of $5,000 or more from companies with which the practitioners interact as part of their professional activities. These practitioner-industry relationships assist in developing new drugs, devices and therapies and in providing medical education aimed at improving quality of care and enhancing clinical outcomes. At the same time, UH understands that these relationships may create a conflict of interest. In providing this information, UH desires to assist patients in talking with their practitioners about industry relationships and how those relationships may impact their medical care.
UH practitioners seek advance approval for certain new industry relationships. In addition, practitioners report their industry relationships and activities, as well as those of their immediate family members, to the UH Office of Outside Interests annually. We review these reports and implement management plans, as appropriate, to address conflicts of interest that may arise in connection with medical research, clinical care and purchasing decisions.
View UH’s policy (PDF) on practitioner-industry relationships.
As of December 31, 2016, Gregory Cooper did not disclose any Outside Relationships with Industry.